Fundraising FoxHealth2047 — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Phenomix Sciencesphenomixsciences.cominMay 2024 · $7.8M
Phenomix Sciences applies data analytics and patient data to enable precision obesity medicine, aiming to guide treatment decisions for anti-obesity medications such as GLP-1s and reduce care costs.
AI & Machine LearningBiotechDigital HealthHealthtechMenlo Park, US
Andres Acosta(Director)inMark Bengall(Executive Officer, Director)Mark Bagnall(Executive Officer, Director)inWilliam Ross Higgins(Executive Officer, Promoter)Karl Ronn(Director)Michael Camilleri(Director)
Co-investorsSoutheast Minnesota Capital Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.